NFE2L2 and glomerulosclerosis: PAS staining showed glomerulosclerosis in the STZ-treated group, which was significantly ameliorated in the digitoflavone-treated Nrf2+/+, but not Nrf2−/−, mice (Fig. 4F, PAS panel, and Fig. 2G).